Hosted on MSN7h
Weight-loss drugs made me fall back in love with old-fashioned dieting
Genevieve Roberts thought weight-loss drugs were a miracle – until excruciating side-effects sent her straight back to a ...
ConsumerAffairs8h
Here are the health pros and cons of GLP-1RA weight loss drugs
New GLP-1RA weight loss drugs like Like Ozempic and Wegovy have become extremely popular in recent months but researchers ...
Pros and cons of weight-loss jabs
Weight-loss jabs, such as Ozempic, Wegovy and Mounjaro, have quickly earned a glowing global reputation for shifting the ...
Weight loss pill could replace injections, would be transformative for millions
While popular drugs like Ozempic and Wegovy are only available as injections, drugmaker Novo Nordisk is working on a more ...
Novo Nordisk CEO says he's confident about Wegovy supply, next-generation weight loss drugs
Ozempic and Wegovy maker Novo Nordisk quieted Wall Street’s concerns with its fourth-quarter results and 2025 outlook.
PA Media on MSN2d
Wegovy obesity drug sales more than double but set to slow
Sales of Wegovy, a prescription weight loss injection, surged to 19.9 billion Danish kroner (£2.2 billion) in the fourth ...
Healthy Returns: Why people quit weight loss, diabetes drugs within one year
A new study examines how cost, side effects, and other factors influence whether people stop GLP-1s, while Noom cuts staff to ...
Tougher rules on weight loss jabs after people with eating disorders get prescriptions
New checks on people wanting drugs such as Wegovy or Mounjaro will include verifying their body mass index in a video ...
Marketing5d
A Weight Watchers Case Study: How Smart Marketing Pays Off
Matthew Denos, PhD is an entrepreneur, biologist, and blogger who studies and reviews Weight Watchers and other clinically proven weight loss programs.